SB 3 MI

Passed One Chamber

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

MI · session 2025-2026 · Senate · bill

A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →

Introduced Jan 8, 2025

Latest action (Apr 24, 2025) referred to Committee on Government Operations

Sponsor (1)

2 coauthors / cosponsors

Jan 8, 2025 INTRODUCED BY SENATOR DARRIN CAMILLERI · upper
Jan 8, 2025 REFERRED TO COMMITTEE ON FINANCE, INSURANCE, AND CONSUMER PROTECTION · upper
Jan 23, 2025 SENATE CO-SPONSOR(S) NAMED: STEPHANIE CHANG · upper
Apr 24, 2025 REPORTED FAVORABLY WITH SUBSTITUTE (S-1) 4/23/2025 · upper
Apr 24, 2025 REFERRED TO COMMITTEE OF THE WHOLE WITH SUBSTITUTE (S-1) · upper
Apr 24, 2025 RULES SUSPENDED FOR IMMEDIATE CONSIDERATION · upper
Apr 24, 2025 REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITH SUBSTITUTE (S-1) · upper
Apr 24, 2025 SUBSTITUTE (S-1) CONCURRED IN · upper
Apr 24, 2025 PLACED ON ORDER OF THIRD READING WITH SUBSTITUTE (S-1) · upper
Apr 24, 2025 RULES SUSPENDED · upper
Apr 24, 2025 PLACED ON IMMEDIATE PASSAGE · upper
Apr 24, 2025 AMENDMENT(S) DEFEATED · upper
Apr 24, 2025 AMENDMENT(S) ADOPTED · upper
Apr 24, 2025 PASSED ROLL CALL # 68 YEAS 20 NAYS 15 EXCUSED 1 NOT VOTING 1 · upper
Apr 24, 2025 received on 04/24/2025 · lower
Apr 24, 2025 read a first time · lower
Apr 24, 2025 referred to Committee on Government Operations · lower

Subjects

Health: pharmaceuticalsState agencies (existing): boards and commissionsState agencies (existing): insurance and financial services

The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.

Loading comments…